Treatment of children with refractory anemia: The Japanese Childhood MDS Study Group Trial (MDS99)

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 1011-1015

  Hasegawa, Daisuke ^a   Manabe, Atsushi ^a   Yagasaki, Hiroshi ^b   Ohtsuka, Yoshitoshi ^c   Inoue, Masami ^d   Kikuchi, Akira ^e   Ohara, Akira ^f   Tsuchida, Masahiro ^g   Kojima, Seiji ^b   Nakahata, Tatsutoshi ^h  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^e SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^f TOHO UNIVERSITY   (Japan)

^g Ibaraki Children's Hospital   (Japan)

^h KYOTO UNIVERSITY   (Japan)

Author keywords

Children; Immunosuppressive therapy; Myelodysplastic syndrome; Refractory anemia

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADENOVIRAL COLITIS; ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; CONTROLLED STUDY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMATOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HUMAN; HUMAN TISSUE; INFANT; INFECTION; JAPANESE; MALE; MONOSOMY 7; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; REFRACTORY ANEMIA; SALMONELLA COLITIS;

ADOLESCENT; ANEMIA, REFRACTORY; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CYCLOSPORINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; METHYLPREDNISOLONE; NEUTROPENIA; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 71049159269     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22121     Document Type: Article

References (22)

1. Luna-Fineman S, Shannon KM,Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients. Blood 1999;93:459-466. (Pubitemid 29035727)
2. Sasaki H, Manabe A, Kojima S, et al. MDS Committee of the Japanese Society of Pediatric Hematology, Japan. Myelodysplastic syndrome in childhood: A retrospective study of 189 patients in Japan. Leukemia 2001;15:1713-1720.
3. Kardos G, Baumann I, Passmore SJ, et al. Refractory anemia in childhood: A retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003;102:1997-2003. (Pubitemid 37122372)
4. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282. (Pubitemid 36266902)
5. Selleri C, Maciejewski JP, Catalano L, et al. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: In vitro and in vivo studies. Cancer 2002;95:1911-1922.
6. Sloand EM, Mainwaring L, Fuhrer M, et al. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 2005;106:841-851. (Pubitemid 41076423)
7. de Vries AC, Langerak AW, Verhaaf B, et al. T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia. Leukemia 2008;22:1170-1174. (Pubitemid 351833784)
8. Molldrem JJ, Caples M, Mavroudis D, et al. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997;99:699-705. (Pubitemid 27519877)
9. Jonásova A,Neuwirtová R, Cermák J, et al. CyclosporinAtherapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998;100:304-309. (Pubitemid 28131061)
10. Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002;100:1570-1574. (Pubitemid 34925129)
11. Shimamoto T, Tohyama K, Okamoto T, et al. Cyclosporin A therapy for patients with myelodysplastic syndrome: Multicenter pilot studies in Japan. Leuk Res 2003;27:783-788. (Pubitemid 36683324)
12. Stadler M, Germing U, Kliche KO, et al. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia 2004;18:460-465. (Pubitemid 38425859)
13. Yoshimi A, Baumann I, Führer M, et al. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia. Haematologica 2007;92:397-400. (Pubitemid 350143550)
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
15. Manabe A, Nakahata T. Experiences on MDS and JMML from Japan. In: Lopes LF, Hasle H, editors. Myelodysplastic and myeloproliferative disorders in children. Sao Paulo, Brazil: Lemar Livraria; 2003. pp. 317-324.
16. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-2302.
17. Nagasawa M, Tomizawa D, Tsuji Y, et al. Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy. Leuk Res 2004;28:315-319. (Pubitemid 37550067)
18. Maciejewski JP, Kim S, Sloand E, et al. Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. Am J Hematol 2000;65:123-131.
19. Führer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: A more severe disease predicts better survival. Blood 2005;106:2102-2104. (Pubitemid 41291726)
20. Mantadakis E, Shannon KM, Singer DA, et al. Transient monosomy 7: A case series in children and review of the literature. Cancer 1999;85:2655-2661. (Pubitemid 29272753)
21. Sloand EM, Yong AS, Ramkissoon S, et al. Granulocyte colonystimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci USA 2006;103:14483-14488. (Pubitemid 44484776)
22. Hirabayashi S, Manabe A, Watanabe S, et al. Myelodysplastic syndrome (MDS) and myeloproliferative disease (MPD) in children: A prospective registration of 222 cases. Blood (ASH Annu Meet Abstr) 2008;112:2678.